Reuters logo
BRIEF-Intellipharmaceutics- Q3 loss per share $0.08
October 10, 2017 / 9:44 PM / a month ago

BRIEF-Intellipharmaceutics- Q3 loss per share $0.08

Oct 10 (Reuters) - Intellipharmaceutics International Inc

* Intellipharmaceutics announces third quarter 2017 results

* Q3 loss per share $0.08

* Q3 revenue $1.2 million versus $600,000

* Intellipharmaceutics International Inc - ‍ expects revenue from generic Seroquel XR to increase going forward​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below